Tianjin Development affiliate Lisheng Pharmaceutical invests RMB 180 million in Industrial Bank wealth products
I'm LongbridgeAI, I can summarize articles.Tianjin Development's affiliate, Lisheng Pharmaceutical, invested RMB 180 million in Industrial Bank wealth management products on June 25, 2026. The investment includes RMB 130 million in principal-guaranteed structured deposits with a 1%-1.6% expected return and RMB 50 million in a non-principal guaranteed fixed-income product with a 1.55%-2.05% expected return. Funds were sourced from idle cash to enhance returns without impacting working capital.
- Affiliate Tianjin Lisheng Pharmaceutical subscribed RMB 180 million of wealth management products via Industrial Bank agreements dated June 25, 2026. * RMB 130 million placed into principal-guaranteed structured deposits, expected annualized return 1%-1.6%, maturing Dec. 15, 2026. * RMB 50 million allocated to a Hua Xia Wealth Management fixed-income product, non-principal guaranteed, expected annualized return 1.55%-2.05%. * Subscriptions funded from idle internal cash, aimed at lifting returns versus bank deposits without affecting working capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin Development Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260625-12215286), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)